Spryte Medical Announces First Participants Enrolled in the INSYTE Trial at Baptist Health Jacksonville

Trial StartnOCT™ Imaging SystemPositive

AI Analysis

Summary

Spryte Medical announced first participant enrollment in the FDA-approved INSYTE IDE trial evaluating the nOCT™ Imaging System for safety and effectiveness in endovascular intracranial aneurysm treatment and follow-up assessment.

Clinical Trial Data

Outcome Details

First participants enrolled in FDA-approved IDE trial (INSYTE Trial)

Importance:5/10

Sentiment:

0.50

IDE trialFDA-approvedintracranial aneurysmendovascularmedical deviceimaging

Related Companies

$MPW $FCHS

Read the original article

Published by GlobeNewswire Clinical Studies on March 3, 2026 3:10 PM

Read Original